Physician profile
Marc Soloman
NPI 1255522082
$13,427.40
in general payments reported to CMS, 2019-2025
51 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,916 · 2020: $525 · 2021: $4,304 · 2022: $1,594 · 2023: $1,412 · 2024: $1,367 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,088.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,184.73 | 2019-2025 | Proclaim, Eterna, Octrode |
| Spinal Simplicity, LLC | $1,964.85 | 2021 | |
| Vertiflex, INC. | $1,569.73 | 2019 | |
| Medtronic, INC. | $847.08 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Si-Bone, INC. | $616.42 | 2021-2024 | |
| Nevro Corp. | $525.22 | 2019-2024 | Senza |
| Tersera Therapeutics LLC | $403.49 | 2019-2023 | Prialt |
| Collegium Pharmaceutical, INC. | $376.00 | 2019-2025 | Belbuca, Xtampza |
| Medtronic USA, INC. | $356.44 | 2019-2020 | |
| Boston Scientific Corporation | $282.97 | 2019-2025 | Avista Mri, Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.38 | 2019-2025 | Relistor |
| Valinor Pharma, LLC | $191.43 | 2023-2025 | Movantik |
| Allergan, INC. | $175.31 | 2019-2021 | |
| Providence Medical Technology, INC. | $146.28 | 2025 | |
| Nalu Medical, INC. | $121.20 | 2021-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Soloman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.